LoginRegister
    Experts differ on ICMR suggestion on banning e-cigarettes, ENDS devicesExperts differ on ICMR suggestion on banning e-cigarettes, ENDS devices
    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drugSwiss company Actelion moves US court against Natco Pharma over generic of its patented drug
    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspensionNatco Pharma files ANDA for generic version of Bosentan tablets for oral suspension
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; DetailsNPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details
    Dr Reddys Labs relaunches Zenatane-generic version of Accutane in USDr Reddys Labs relaunches Zenatane-generic version of Accutane in US
    Merck wins USFDA approval for antibiotic Zerbaxa to treat pneumoniaMerck wins USFDA approval for antibiotic Zerbaxa to treat pneumonia
    Manipal Group appoints Subrat Mohanty as Group PresidentManipal Group appoints Subrat Mohanty as Group President
    Domestic growth helped Indian pharma companies offset pricing pressure in US: FitchDomestic growth helped Indian pharma companies offset pricing pressure in US: Fitch
    Astellas Pharma, Seattle Genetics drug shows rapid tumour shrinkage in advanced bladder cancerAstellas Pharma, Seattle Genetics drug shows rapid tumour shrinkage in advanced bladder cancer
    Cadila Healthcare gets 11 USFDA observations for St Louis facilitiesCadila Healthcare gets 11 USFDA observations for St Louis facilities
    Dr ReddyDr Reddy's Laboratories in process to seek permission for launch of 70 products in China
    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer careRoche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer...
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X